Chinese robotics giant Unitree soars 600% in Shanghai debut

On Wednesday morning in Shanghai, shares in Unitree Robotics began trading on the Star Market—China's technology exchange—and the price nearly doubled in the opening hours. The stock opened at 1,100 yuan, equivalent to about £120, before settling around 900 yuan as some early buyers took profits. The surge reflected something larger than a single company's market debut: it was a visible marker of how thoroughly the robotics industry has shifted, and where the money now believes the future lies.

Unitree, officially registered as Yushu Technology Co Ltd, was founded a decade ago in Hangzhou, a city in eastern China that has become a hub for robotics development. The company makes everything from sensors and robotic arms to four-legged machines and humanoid robots that walk on two legs. Last year, it shipped more than 5,500 humanoid units. More remarkably, it actually turned a profit—278 million yuan in 2025—which distinguishes it from many robotics firms that burn cash while chasing the technology. The company's machines are not the most sophisticated in the world, but they are substantially cheaper. Unitree's four-legged robot dogs start at $2,700. Boston Dynamics, the American competitor, charges roughly $70,000 for a comparable machine called Spot. The gap is not accidental; it reflects a deliberate strategy to dominate through price and volume rather than premium positioning.

This week, Unitree's robots are competing in the World Humanoid Robot Games in Beijing, an event that draws hundreds of teams to test machines in tasks ranging from running and football to opening boxes and shelving library books. In February, the company's G1 humanoid robots performed martial arts during China's Spring Festival Gala, a nationally televised broadcast that reaches hundreds of millions of viewers. The display was carefully choreographed—a public relations moment designed to signal that Chinese robotics had arrived at a level of sophistication worth watching. Researchers noted the performance showed capabilities "in a way we'd never seen before," and the broader message was unmistakable: this is an industry on the rise, and China is leading it.

The context for Unitree's listing extends beyond the company itself. China's government has designated robotics as a strategic priority, part of a broader push to dominate advanced technology sectors. Between 2020 and 2024, the number of robotics firms in China more than tripled, fueled by state investment and policy support. The aging of China's population—a demographic reality that will shrink the working-age cohort in coming decades—has made automation not merely desirable but necessary. Robots offer a way to maintain economic output even as the labor force contracts. For Beijing, they represent a solution to a structural problem.

The rivalry with the United States has become explicit. In July, the Trump administration announced plans to ban imports of Chinese-made humanoid and quadruped robots, citing national security concerns and the need to protect American manufacturing. Beijing rejected the claim as political. The US has also imposed restrictions on other Chinese technologies—artificial intelligence models, electric vehicles—in an effort to slow China's advance. Yet the restrictions may come too late. Chinese firms have become deeply embedded in global manufacturing supply chains. Other countries face a difficult choice: reduce reliance on Chinese suppliers and risk disrupting their own factories, or accept the status quo and watch Chinese companies consolidate their position.

American robotics companies have not yet commercialized their humanoid machines at scale. Tesla announced plans to manufacture its Optimus robots at a California facility, but deliveries remain in the future. Boston Dynamics, owned majority by Hyundai, says it will deploy human-like machines in factories within two years. Amazon tested humanoid robots in warehouses in 2023 and continues research. None of these efforts have translated into the kind of market presence that Unitree has already achieved. One prominent robotics researcher summed it up plainly: "We no longer hear about American robotics companies in the news. It's the Chinese robot companies that are making news today. They have replaced America as the cool kids on the block."

Unitree's listing is unlikely to be the last. UBTech Robotics, a smaller Chinese competitor, listed in Hong Kong nearly three years ago and recently unveiled what state media called a "hyper-realistic" robot designed for emotional support. Other manufacturers—Leju Robotics, AgiBot—are expected to pursue public listings in the coming months. The wave of offerings will test whether investor enthusiasm for humanoid robotics is genuine or speculative. Some experts have raised questions about whether demand exists outside industrial and commercial settings. Robots remain years away from functioning reliably in homes, researchers say. Battery life, privacy safeguards, and mechanical reliability all need improvement. For now, the market is factories and hospitals. But the capital flowing into the sector suggests investors believe the residential market will eventually follow.